Molecular requirements for lineage commitment in the thymus - Antibody-mediated receptor engagements reveal a central role for lck in lineage decisions

Immunological Reviews

Volumn 165, Issue , 1998, Pages 181-194

  Basson, M Albert ^a   Bommhardt, Ursula ^a,b   Mee, P Joe ^a   Tybulewicz, Victor L J ^a   Zamoyska, Rose ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

CELL LINEAGE; ENZYME ACTIVITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; REVIEW; THYMOCYTE; THYMUS;

EID: 0031786030     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01239.x     Document Type: Review

References (94)

1. Kisielow P, von Boehmer H. Development and selection of T cells: facts and puzzles. Adv Immunol 1995;58:87-210.
2. Hogquist K, Bevan M. The nature of the peptide/MHC ligand involved in positive selection. Semin Immunol 1996;8:63-68.
3. Hogquist KA, et al. Identification of a naturally occurring ligand for thymic positive selection. Immunity 1997;6:389-399.
4. Hu Q, et al. Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes. Immunity 1997;7:221-231.
5. Jameson SC, Bevan MJ. T-cell selection. Curr Opin Immunol 1998;10:214-219.
6. Kostelny SA, Cole MS, Yun Tso J. Formation of a bispecific antibody by the use of leucine zippers. J Immunol 1992;148:1547-1553.
7. Bommhardt U, Cole MS, Yun Tso J, Zamoyska R. Signals through CD8 or CD4 can induce commitment to the CD4 lineage in the thymus. Eur J Immunol 1997;27:1152-1163.
8. Basson MA, Bommhardt U, Cole MS, Tso JY, Zamoyska R. CD3 ligation on immature thymocytes generates antagonist-like signals appropriate for CD8 lineage commitment, independently of T cell receptor specificity. J Exp Med 1998;187:1249-1260.
9. Weiss A, Imboden J, Hardy K, Manger B, Terhorst C, Stobo J. The role of the T3/antigen receptor complex in T cell activation. Annu Rev Immunol 1986;4:593-619.
10. Gupta S. Mechanisms of transmembrane signalling in human T cell activation. Mol Cell Biochem 1989;91:45-50.
11. Ratcliffe MJH, Coggeshall KM, Newell MK, Julius MH. T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor. J Immunol 1992;148:1643-1651.
12. Henrickson M, Reid J, Bellet JS, Sawchuk SS, Hirsch R. Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR αβ (H57-597) and CD3 (145-2C11). Transplantation 1995;60:828-835.
13. Sawchuk SS, Gates R, Hirsch R. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody. Transplantation 1995;60:1331-1337.
14. Chatenoud L, Primo J, Bach J-F. CD3 antibody-induced dominant self-tolerance in overtly diabetic NOD mice. J Immunol 1997;158:2947-2954.
15. Madrenas J, Chau LA, Smith J, Bluestone JA, Germain RN. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J Exp Med 1997;185:219-229.
16. Smith JA, Yun Tso J, Clark MR, Cole MS, Bluestone JA. Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J Exp Med 1997;185:1413-1422.
17. Alam SM, et al. T-cell-receptor affinity and thymocyte positive selection. Nature 1996;381:616-620.
18. Shaw AS, Dustin ML. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 1997;6:361-369.
19. Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;375:148-151.
20. Germain RN. T-cell signalling: the importance of receptor clustering. Curr Biol 1997;7:640-644.
21. Wülfing C, Rabinowitz JD, Beeson C, Sjaastad MD, McConnell HM, Davis MM. Kinetics and extent of T cell activation as measured with the calcium signal. J Exp Med 1997;185:1815-1825.
22. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989;337:181-183.
23. Levelt CN, Ehrfield A, Eichmann K. Regulation of thymocyte development through CD3. I. Timepoint of ligation of CD3ε determines clonal deletion or induction of developmental program. J Exp Med 1993;177:707-716.
24. Lerner A, et al. Cross-linking of T-cell receptors on double-positive thymocytes induces a cytokine-mediated stromal activation process linked to cell death. EMBO J 1996;15:5876-5887.
25. + thymocytes by two distinct mechanisms differing in their requirements for CD28 costimulation: implications for negative selection in the thymus. J Exp Med 1997;186:1911-1922.
26. Page DM, Kane LP, Onami TM, Hedrick SM. Cellular and biochemical requirements for thymocyte negative selection. Semin Immunol 1996;8:69-82.
27. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994;76:17-27.
28. Ashton-Rickardt PG, et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994;76:651-663.
29. Sebzda E, Wallace VA, Mayer J, Yeung RSM, Mak TW, Ohashi PS. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 1994;263:1615-1618.
30. Sebzda E, et al. Mature T cell reactivity altered by peptide agonist that induces positive selection. J Exp Med 1996;183:1093-1104.
31. + T cells. Immunity 1995;3:79-86.
32. Müller K-P, Kyewski BA. T cell receptor (TcR) targetting in mice lacking CD4 or major histocompatibility complex (MHC) class II: rescue of CD4 T cell lineage without co-engagement of TcR/CD4 by MHC class II. Eur J Immunol 1995;25:896-902.
33. + T cells by TcR ligation without aggregation even in the absence of MHC. Nature 1994;371:67-70.
34. Cibotti R, Punt JA, Dash KS, Sharrow SO, Singer A. Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals. Immunity 1997;6:245-255.
35. + thymocytes to the CD4 lineage without TcR engagement. Int Immunol 1996;8:297-306.
36. Takahama Y, Nakauchi H. Phorbol ester and calcium ionophore can replace TCR signals that induce positive selection of CD4 T cells. J Immunol 1996;157:1508-1513.
37. Jameson SC, Bevan MJ. T cell receptor antagonists and partial agonists. Immunity 1995;1:1-11.
38. Takahama Y, Tokoro Y, Sugawara T, Negishi I, Nakauchi H. Pertussis toxin can replace T cell receptor signals that induce positive selection of CD8 T cells. Eur J Immunol 1997;27:3318-3331.
39. Conroy LA, Jenkinson EJ, Owen JJ, Michell RH. Phosphatidylinositol 4,5-bisphosphate hydrolysis accompanies T cell receptor-induced apoptosis of murine thymocytes within the thymus. Eur J Immunol 1995;25:1828-1835.
40. Zerrahn J, Held W, Raulet DH. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 1997;88:627-636.
41. Veillette A, Zuniga-Pflucker JC, Bolen JB, Kruisbeek AM. Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways. J Exp Med 1989;170:1671-1680.
42. Luo K, Sefton B. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site. Mol Cell Biol 1990;10:5305-5313.
43. lck tyrosine protein kinase. J Biol Chem 1991;266:16219-16225.
44. lck correlates with impaired function in vitro and lack of expression in vivo. Nature 1989;342:278-281.
45. Fung-Leung W-P, et al. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 1991;65:443-449.
46. Lucas B, Vasseur F, Penit C. Normal sequence of phenotypic transitions in one cohort of 5-bromo-2′-deoxyurine-pulse-labelled thymocytes. J Immunol 1993;151:4574-4582.
47. Kersh GJ, Allen PM. Essential flexibility in the T-cell recognition of antigen. Nature 1996;380:495-498.
48. Rabinowitz JD, et al. Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity 1996;5:125-135.
49. Sloan-Lancaster J, Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol 1996;14:1-27.
50. + cytotoxic T cells after stimulation with T cell agonists, partial agonists and antagonists. Eur J Immunol 1997;17:3414-3419.
51. La Face DM, et al. Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. J Immunol 1997;158:2057-2064.
52. Mannie MD, Rosser JM, White GA. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. J Immunol 1995;154:2642-2654.
53. Spain LM, Jorgensen JL, Davis MM, Berg LJ. A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J Immunol 1994;152:1709-1717.
54. Goldrath AW, Hogquist KA, Bevan MJ. CD8 lineage commitment in the absence of CD8. Immunity 1997;6:633-642.
55. + single positive cells with a class II major histocompatibility complex-restricted receptor. Eur J Immunol 1994;180:25-34.
56. Sloan-Lancaster J, Shaw AS, Rothbard J, Allen PM. Partial T cell signalling: altered phospho-ζ and lack of ZAP70 recruitment in APL-induced T cell anergy. Cell 1994;79:913-922.
57. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN. ζ-Phosphorylation without ZAP-70 activation induced by TcR antagonists or partial agonists. Science 1995;267:515-518.
58. + T cells in response to antagonist ligands. J Exp Med 1996;184:149-157.
59. Cobbold S, Qin S, Leong L, Martin G, Waldmann H. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol Rev 1992;129:165-201.
60. MacDonald HR, Galsebrook AL, Bron C, Kelso A, Cerottini JC. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on CTL: possible implications for the affinity of CTL antigen receptors. Immunol Rev 1982;68:89-115.
61. Shimonkevitz R, Luescher B, Cerottini JC, MacDonald HR. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function. J Immunol 1985;135:892-899.
62. d-restricted cytotoxic T lymphocytes. J Exp Med 1991;173:849-858.
63. Kwan Lim G, Ong T, Aosai F, Stauss H, Zamoyska R. Is CD8 dependence a true reflection of TCR affinity for antigen? Int Immunol 1993;5:1219-1228.
64. Feito M, et al. CD4 dependence of activation threshold and TCR signalling in mouse T lymphocytes. Scand J Immunol 1997;45:166-174.
65. Janeway CJ. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 1992;10:645-674.
66. Miceli M, Parnes J. Role of CD4 and CD8 in T cell activation and differentiation. Adv Immunol 1993;53:59-122.
67. Straus DB, Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992;70:585-593.
68. Alberola-Ila J, Takaki S, Kerner JD, Perlmutter RM. Differential signaling by lymphocyte antigen receptors. Annu Rev und Immunol 1997;15:125-154.
69. McFarland EDC, Hurley TR, Pingel JT, Sefton BM, Shaw A, Thomas ML. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc Natl Acad Sci USA 1993;90:1402-1406.
70. Sieh M, Bolen JB, Weiss A. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J 1993;12:315-321.
71. Stone JD, et al. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-ζ, ZAP-70. J Immunol 1997;158:5773-5782.
72. Kishihara K, et al. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 1993;74:143-56.
73. + thymocytes, and B cell maturation. J Exp Med 1996;183:1707-1718.
74. Turka LA, Linsley PS, Paine R III, Schieven GL, Thompson CB, Ledbetter JA. Signal transduction via CD4, CD8, and CD28 in mature and immature thymocytes. Implications for thymic selection. J Immunol 1991;146:1428-1436.
75. Matechak EO, Killeen N, Hedrick SM, Fowlkes BJ. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. Immunity 1996;4:337-347.
76. Zal T, Volkmann A, Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med 1994;180:2089-2099.
77. Corbella P, et al. Functional commitment to helper T cell lineage precedes positive selection and is independent of T cell receptor MHC specificity. Immunity 1994;1:269-276.
78. Itano A, Salmon P, Kioussis D, Tolaini M, Corbella P, Robey E. The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells. J Exp Med 1996;183:731-741.
79. Norment AM, Forbush KA, Nguyen N, Malissen M, Perlmutter RM. Replacement of pre-T cell receptor signaling functions by the CD4 coreceptor. J Exp Med 1997;185:121-130.
80. Zal T, Weiss S, Mellor A, Stockinger B. Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function. Proc Natl Acad Sci USA 1996;93:9102-9107.
81. lck with CD4 inhibits the induction of growth through the αβ T-cell receptor. Nature 1992;358:328-331.
82. Teh H-S, et al. Participation of CD4 coreceptor molecules in T-cell repertoire selection. Nature 1991;349:241-243.
83. lck. Eur J Immunol 1992;22:735-743.
84. Zhang J, Salojin K, Delovitch TL. Sequestration of CD4-associated Lck from the TCR complex may elicit T cell hyporesponsiveness in nonobese diabetic mice. J Immunol 1998;160:1148-1157.
85. Smyth L, et al. Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes. Proc Natl Acad Sci USA 1998;95:8193-8198.
86. Sharp LL, Schwarz DA, Bott CM, Marshall CJ, Hedrick SM. The influence of the MAPK pathway on T cell lineage commitment. Immunity 1997;7:609-618.
87. Robey E, et al. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 1996;87:483-492.
88. Volkmann A, Barthlott T, Weiss S, Frank R, Stockinger B. Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage. J Exp Med 1998;188:1083-1089.
89. Nakagawa T, et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998;280:450-453.
90. Douek DC, Altmann DM. HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int Immunol 1997;9:355-364.
91. Karlsson L, Surh CD, Sprent J, Peterson PA. A novel Class II MHC molecule with unusual tissue distribution. Nature 1991;351:485-488.
92. Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P. Negative regulation by HLA-DO of MHC Class II-restricted antigen processing. Science 1997;278:106-109.
93. Ignatowicz L, et al. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity 1997;7:179-186.
94. Nakano N, Rooke R, Benoist C, Mathis D. Positive selection of T cells induced by viral delivery of neopeptides to the thymus. Science 1997;275:678-683.